Diabetes Prevention Special Issue - Guest Editors

Prof Nick Wareham

Guest Editor, PLOS Medicine Diabetes Prevention

Professor Nick Wareham is Director of the MRC Epidemiology Unit, University of Cambridge and an Honorary Consultant at Addenbrooke’s Hospital, Cambridge.  He is also Director of the UKCRC Centre of Public Health Research Excellence in Diet and Physical Activity (CEDAR).

Professor Wareham undertakes research into the aetiological determinants of diabetes, obesity and related metabolic disorders and the translation of that epidemiological understanding into preventive action.  His work on gene-environment interaction is based on quantitative trait studies and large scale population-based cohort studies. He is a Principal Investigator on the EPIC-Norfolk and Fenland studies and the EPIC-InterAct study, which aims to investigate how genes and lifestyle factors interact to lead to type 2 diabetes.  A key element of his work has been the accurate measurement of lifestyle exposures including physical activity and he has developed and evaluated novel methods for measuring energy expenditure in free-living individuals in population-based studies.  He is co-lead of the ADDITION study, a trial of screening for diabetes and intensive cardiovascular risk reduction undertaken in 3 European countries.

Competing Interests: None

Prof William Herman

Guest Editor, PLOS Medicine Diabetes Prevention

Professor William Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine and Epidemiology, and Director of the Michigan Center for Diabetes Translational Research. His clinical interests focus on the management of diabetes, its complications, and comorbidities. His research focuses on the broad areas of clinical trials, epidemiology, health services research, and clinical economics.

Professor Herman has served as a principal investigator for the Diabetes Control and Complications Trial (DCCT), the Diabetes Prevention Program (DPP), and the Glycemia Reduction Approaches for Diabetes: A Comparative Effectiveness (GRADE) Study. Dr. Herman’s research has also focused on screening for diabetes and diabetic complications, and diabetes epidemiology. He has explored the impact of health system organization and structure on the processes and outcomes of diabetes care and directs the DCCT, DPP, and GRADE Study Economic Workgroups. He chairs the American Diabetes Association Professional Practice Committee and the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) Workgroup on Diabetes Quality Measures.

Competing Interests: Professor Herman serves on DSMBs for both Merck and Lexicon Pharmaceuticals.